Eikon Therapeutics

formerly EikonIPO

Bringing breakthrough therapeutics to patients with serious illnesses

Public · Hayward, United States · Founded 2019 · $1.1B raised

Employees
201–500
Founded
2019
Business Model
B2B
Total Funding
$1.1B
Last Round
$350.7M Series DFeb 2025
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Eikon Therapeutics is a clinical-stage biopharmaceutical company that has built the world's first high-throughput single-molecule tracking (htSMT) platform, enabling visualization of hundreds of thousands of protein motion events in living cells in under a second. Founded on Nobel Prize-winning super-resolution microscopy by Eric Betzig, Eikon uses this platform to discover and develop breakthrough oncology and neurological therapeutics. The company completed an IPO in early 2026, raising $381 million.

Summary

Eikon Therapeutics is an Artificial Intelligence company based in Hayward, United States, founded in 2019. It has raised $1.1B in total across 4 rounds, most recently a $350.7M Series D round in Feb 2025. Investors include T. Rowe Price, Andreessen Horowitz and Lux Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOFeb 2026
$381.0M

Sign up to see all 5 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Eikon Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/eikon-therapeutics"><img src="https://indexed.vc/api/badge/company/eikon-therapeutics" alt="Eikon Therapeutics on Indexed.vc" width="260" height="76" /></a>